Melatonin in Pulmonary Arterial Hypertension: A Promising Adjunctive Therapy
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Shaher Yar, Seyed R. Rafieossadat, Taraneh Tadayon, Zahin Shahriar |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension
by: Alicia de la Fuente, et al.
Published: (2025)
by: Alicia de la Fuente, et al.
Published: (2025)
Heart Rate Variability in Pulmonary Arterial Hypertension
by: Bishal Gyawali, et al.
Published: (2025)
by: Bishal Gyawali, et al.
Published: (2025)
Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report
by: Daniel J. Strick, et al.
Published: (2025)
by: Daniel J. Strick, et al.
Published: (2025)
Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
by: Marshaleen Henriques King, et al.
Published: (2025)
by: Marshaleen Henriques King, et al.
Published: (2025)
Prognostic Role of Platelets in Pulmonary Arterial Hypertension
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2025)
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2025)
Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial Hypertension
by: Kyle Norton, et al.
Published: (2026)
by: Kyle Norton, et al.
Published: (2026)
Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research
by: Jean M. Elwing, et al.
Published: (2025)
by: Jean M. Elwing, et al.
Published: (2025)
How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
by: Ivan M. Robbins, et al.
Published: (2025)
by: Ivan M. Robbins, et al.
Published: (2025)
Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial Hypertension
by: Hilary M. DuBrock, et al.
Published: (2025)
by: Hilary M. DuBrock, et al.
Published: (2025)
Risk Assessment Models and Event‐Free Survival in Pulmonary Arterial Hypertension
by: Clara Hjalmarsson, et al.
Published: (2025)
by: Clara Hjalmarsson, et al.
Published: (2025)
Towards a Safe Pathway to Biological Parenthood for Pulmonary Arterial Hypertension
by: Jamie D. Ingram, et al.
Published: (2026)
by: Jamie D. Ingram, et al.
Published: (2026)
Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension
by: Teresa Segura de la Cal, et al.
Published: (2026)
by: Teresa Segura de la Cal, et al.
Published: (2026)
Association of Immunoglobulin E With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
by: Fengxia Wu, et al.
Published: (2026)
by: Fengxia Wu, et al.
Published: (2026)
The Role of the Cellular Communication Network Protein Family in Pulmonary Arterial Hypertension
by: Carly E. Byrd, et al.
Published: (2026)
by: Carly E. Byrd, et al.
Published: (2026)
Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?
by: Ambalavanan Arunachalam, et al.
Published: (2025)
by: Ambalavanan Arunachalam, et al.
Published: (2025)
Identification of Diagnostic Biomarkers Causally Associated With Gut Microbiota and Pulmonary Arterial Hypertension
by: Ming Sun, et al.
Published: (2025)
by: Ming Sun, et al.
Published: (2025)
Programmatic Approach to Outpatient Cardiac Catheterization in Children With Stable Pulmonary Arterial Hypertension
by: Gregory T. Adamson, et al.
Published: (2025)
by: Gregory T. Adamson, et al.
Published: (2025)
Methamphetamine‐Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management
by: Namita Sood, et al.
Published: (2026)
by: Namita Sood, et al.
Published: (2026)
Macitentan Plus Tadalafil Single‐Tablet Combination Therapy in Chinese Patients With Pulmonary Arterial Hypertension: A Subgroup Analysis of the A DUE Study
by: Fenling Fan, et al.
Published: (2025)
by: Fenling Fan, et al.
Published: (2025)
Comparing Pulmonary Arterial Hypertension Care in Urban and Rural Settings: Treatment Patterns and Risk Trajectories
by: Amrit K. Deol, et al.
Published: (2025)
by: Amrit K. Deol, et al.
Published: (2025)
A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension
by: Rajan Saggar, et al.
Published: (2025)
by: Rajan Saggar, et al.
Published: (2025)
Role of a New Walk Test in Pulmonary Arterial Hypertension: A Retrospective Cohort Study
by: Junhao Jin, et al.
Published: (2025)
by: Junhao Jin, et al.
Published: (2025)
Assessment of the Relationship Between the Six‐Minute Walk Test (6MWT) With Serum Chloride Level and Mean Pulmonary Arterial Pressure in Patients With Pulmonary Arterial Hypertension
by: Sepideh Hejazi, et al.
Published: (2025)
by: Sepideh Hejazi, et al.
Published: (2025)
Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real‐World Data
by: Julia R. DiBello, et al.
Published: (2026)
by: Julia R. DiBello, et al.
Published: (2026)
Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center
by: Cyrus A. Kholdani, et al.
Published: (2025)
by: Cyrus A. Kholdani, et al.
Published: (2025)
Why Wait for Sick People to Get Sicker? The Paradox of the Treatment of Patients With Pulmonary Arterial Hypertension
by: Mauricio Orozco‐Levi, et al.
Published: (2025)
by: Mauricio Orozco‐Levi, et al.
Published: (2025)
Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension
by: Daniel J. Lachant, et al.
Published: (2025)
by: Daniel J. Lachant, et al.
Published: (2025)
Repair of Sinus Venosus Atrial Septal Defect in 2 Patients With Severe Pulmonary Arterial Hypertension
by: Ryo Sakuma, et al.
Published: (2026)
by: Ryo Sakuma, et al.
Published: (2026)
Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis
by: Adam Engel Sällberg, et al.
Published: (2026)
by: Adam Engel Sällberg, et al.
Published: (2026)
Sotatercept for Decompensated Pulmonary Arterial Hypertension Requiring VA ECMO: First Canadian ICU Experience
by: Jonathan Taylor, et al.
Published: (2026)
by: Jonathan Taylor, et al.
Published: (2026)
Lifesaving Compassionate‐Use of Sotatercept in a 12‐Year‐old With Idiopathic Pulmonary Arterial Hypertension
by: Weronika Pelczar‐Płachta, et al.
Published: (2026)
by: Weronika Pelczar‐Płachta, et al.
Published: (2026)
Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries
by: Barbro Kjellström, et al.
Published: (2025)
by: Barbro Kjellström, et al.
Published: (2025)
Flow Cytometric Determination of Circulating Progenitor Cells in Patients With Pulmonary Arterial Hypertension: A Systematic Review
by: Kimia Heydari, et al.
Published: (2025)
by: Kimia Heydari, et al.
Published: (2025)
History of Adverse Pregnancy Outcomes in Women With Pulmonary Arterial Hypertension: A Single‐Center Pilot Study
by: Jessica B. Badlam, et al.
Published: (2025)
by: Jessica B. Badlam, et al.
Published: (2025)
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
by: Brandon Budhram, et al.
Published: (2025)
by: Brandon Budhram, et al.
Published: (2025)
Heart Rate Variability as a Marker of Disease Severity in Pulmonary Arterial Hypertension: A Prospective Cohort Study
by: Arun Jose, et al.
Published: (2025)
by: Arun Jose, et al.
Published: (2025)
Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2024)
by: Haowen Jiang, et al.
Published: (2024)
Identification of RUNX1 as a Biomarker for Right Ventricular Remodeling in Pulmonary Arterial Hypertension Using WGCNA
by: Wenjie Chen, et al.
Published: (2026)
by: Wenjie Chen, et al.
Published: (2026)
Sotatercept in TBX4 Associated Heritable Pulmonary Arterial Hypertension: A Case Report of a Super Responder
by: Jop W. Schneijdenberg, et al.
Published: (2026)
by: Jop W. Schneijdenberg, et al.
Published: (2026)
A Randomized Controlled Trial of Specialty Palliative Care to Improve Health‐Related Quality of Life in Pulmonary Arterial Hypertension
by: Hilary M. DuBrock, et al.
Published: (2026)
by: Hilary M. DuBrock, et al.
Published: (2026)
Similar Items
-
Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension
by: Alicia de la Fuente, et al.
Published: (2025) -
Heart Rate Variability in Pulmonary Arterial Hypertension
by: Bishal Gyawali, et al.
Published: (2025) -
Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report
by: Daniel J. Strick, et al.
Published: (2025) -
Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
by: Marshaleen Henriques King, et al.
Published: (2025) -
Prognostic Role of Platelets in Pulmonary Arterial Hypertension
by: Caio Julio Cesar dos Santos Fernandes, et al.
Published: (2025)